DOPACIS

This brand name is authorized in France, Malta, Spain.

Active ingredients

The drug DOPACIS contains one active pharmaceutical ingredient (API):

1	Fluorodopa ¹⁸F UNII 2C598205QX - FLUORODOPA F-18
	Fluorodopa F18 is a radioactive diagnostic agent used in PET imaging. In dopaminergic nerve terminals in the brain, fluorodopa (FDOPA) F18 is decarboxylated by amino acid decarboxylase to fluorodopamine (FDA) F18 and stored in presynaptic vesicles in the brain. The accumulation of F18 FDA in the striatum is visually detected in the PET scan.
	Read more about Fluorodopa ¹⁸F

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DOPACIS Solution for injection	MPI, EU: SmPC	Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09IX05	Fluorodopa (18F)	V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	73797
FR	Base de données publique des médicaments	62062343
MT	Medicines Authority	MA826/00101